Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hölscher C[au]:

Editorial. Hölscher C et al. Alzheimers Dement. (2014)

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models. Hölscher C et al. Neuropharmacology. (2018)

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Olmos-Alonso A et al. Brain. (2016)

Search results

Items: 1 to 50 of 324

1.

Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ.

Xie Z, Zhao J, Wang H, Jiang Y, Yang Q, Fu Y, Zeng H, Hölscher C, Xu J, Zhang Z.

Biomed Pharmacother. 2020 Apr;124:109886. doi: 10.1016/j.biopha.2020.109886. Epub 2020 Jan 27.

2.

Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.

Massie AB, Holscher CM, Henderson ML, Fahmy LM, Thomas AG, Al Ammary F, Getsin SN, Snyder JJ, Lentine KL, Garg AX, Segev DL.

JAMA Surg. 2020 Jan 22:e195472. doi: 10.1001/jamasurg.2019.5472. [Epub ahead of print]

PMID:
31968070
3.

The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.

Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, Yan N, Xing Y, Hölscher C, Wang Z.

Brain Behav. 2020 Jan 20:e01505. doi: 10.1002/brb3.1505. [Epub ahead of print]

4.

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.

Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hölscher C.

J Parkinsons Dis. 2020 Jan 13. doi: 10.3233/JPD-191768. [Epub ahead of print]

PMID:
31958096
5.

Outcomes after declining a steatotic donor liver for liver transplant candidates in the United States.

Jackson KR, Bowring MG, Holscher C, Haugen CE, Long JJ, Liyanage L, Massie AB, Ottmann S, Philosophe B, Cameron AM, Segev DL, Garonzik-Wang J.

Transplantation. 2019 Nov 20. doi: 10.1097/TP.0000000000003062. [Epub ahead of print]

PMID:
31815898
6.

A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice.

Wang ZJ, Han YF, Zhao F, Yang GZ, Yuan L, Cai HY, Yang JT, Holscher C, Qi JS, Wu MN.

Horm Behav. 2020 Feb;118:104640. doi: 10.1016/j.yhbeh.2019.104640. Epub 2019 Nov 28.

PMID:
31765661
7.

Successful Mentor-Mentee Relationship.

Nassour I, Balentine C, Boland GM, Chu D, Habermann E, Holscher C, Idrees K, In H, Kimbrough MK, Mitchem J, Warner SG, Karakousis G; Committee on Academic Advancement of the Association for Academic Surgery.

J Surg Res. 2019 Nov 13. pii: S0022-4804(19)30722-X. doi: 10.1016/j.jss.2019.09.066. [Epub ahead of print] No abstract available.

PMID:
31733816
8.

Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.

Muzaale AD, Massie AB, Al Ammary F, Henderson ML, Purnell TS, Holscher CM, Garonzik-Wang J, Locke JE, Snyder JJ, Lentine KL, Segev DL.

Am J Kidney Dis. 2019 Nov 12. pii: S0272-6386(19)31013-3. doi: 10.1053/j.ajkd.2019.08.020. [Epub ahead of print]

PMID:
31732232
9.

GIP has neuroprotective effects in Alzheimer and Parkinson's disease models.

Zhang ZQ, Hölscher C.

Peptides. 2019 Nov 6:170184. doi: 10.1016/j.peptides.2019.170184. [Epub ahead of print] Review.

PMID:
31705913
10.

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.

Salles GN, Calió ML, Hölscher C, Pacheco-Soares C, Porcionatto M, Lobo AO.

Neuropharmacology. 2020 Jan 1;162:107813. doi: 10.1016/j.neuropharm.2019.107813. Epub 2019 Oct 16.

PMID:
31628935
11.

Temporal trends in utilization and outcomes of steatotic donor livers in the United States.

Jackson KR, Motter JD, Haugen CE, Holscher C, Long JJ, Massie AB, Philosophe B, Cameron AM, Garonzik-Wang J, Segev DL.

Am J Transplant. 2019 Oct 14. doi: 10.1111/ajt.15652. [Epub ahead of print]

PMID:
31608597
12.

Posttransplant outcomes for cPRA-100% recipients under the new Kidney Allocation System.

Jackson KR, Holscher C, Motter JD, Desai N, Massie AB, Garonzik-Wang J, Alachkar N, Segev DL.

Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002989. [Epub ahead of print]

PMID:
31577673
13.

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation.

Lentine KL, Holscher CM, Naik AS, Lam NN, Segev DL, Garg AX, Axelrod D, Xiao H, Henderson ML, Massie AB, Kasiske BL, Hess GP, Hsu CY, Park M, Schnitzler MA.

Transplant Direct. 2019 Jul 25;5(8):e474. doi: 10.1097/TXD.0000000000000913. eCollection 2019 Aug.

14.

Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

Holscher CM, Haugen CE, Jackson KR, Garonzik Wang JM, Waldram MM, Bae S, Locke JE, Reed RD, Lentine KL, Gupta G, Weir MR, Friedewald JJ, Verbesey J, Cooper M, Segev DL, Massie AB.

Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1493-1499. doi: 10.2215/CJN.04020419. Epub 2019 Sep 19.

PMID:
31537534
15.

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke.

Yang X, Feng P, Zhang X, Li D, Wang R, Ji C, Li G, Hölscher C.

Neuropharmacology. 2019 Nov 1;158:107748. doi: 10.1016/j.neuropharm.2019.107748. Epub 2019 Aug 26.

PMID:
31465784
16.

Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Lentine KL, Koraishy FM, Sarabu N, Naik AS, Lam NN, Garg AX, Axelrod D, Zhang Z, Hess GP, Kasiske BL, Segev DL, Henderson ML, Massie AB, Holscher CM, Schnitzler MA.

Clin Transplant. 2019 Oct;33(10):e13696. doi: 10.1111/ctr.13696. Epub 2019 Sep 8.

PMID:
31421057
17.

D-Ser2-oxyntomodulin ameliorated Aβ31-35-induced circadian rhythm disorder in mice.

Wang L, Zhao J, Wang CT, Hou XH, Ning N, Sun C, Guo S, Yuan Y, Li L, Hölscher C, Wang XH.

CNS Neurosci Ther. 2019 Aug 14. doi: 10.1111/cns.13211. [Epub ahead of print]

PMID:
31411808
18.

National Variation in Increased Infectious Risk Kidney Offer Acceptance.

Holscher CM, Bowring MG, Haugen CE, Zhou S, Massie AB, Gentry SE, Segev DL, Garonzik Wang JM.

Transplantation. 2019 Oct;103(10):2157-2163. doi: 10.1097/TP.0000000000002631.

PMID:
31343577
19.

Association between Living Kidney Donor Post-Donation Hypertension and Recipient Graft Failure.

Holscher CM, Ishaque T, Haugen CE, Jackson KR, Garonzik Wang JM, Yu Y, Al Ammary F, Segev DL, Massie AB.

Transplantation. 2019 Jul 15. doi: 10.1097/TP.0000000000002832. [Epub ahead of print]

PMID:
31335778
20.

Display clutter and its effects on visual attention distribution and financial risk judgment.

Ognjanovic S, Thüring M, Murphy RO, Hölscher C.

Appl Ergon. 2019 Oct;80:168-174. doi: 10.1016/j.apergo.2019.05.008. Epub 2019 Jun 3.

21.

Neighborhood environments influence emotion and physiological reactivity.

Hackman DA, Robert SA, Grübel J, Weibel RP, Anagnostou E, Hölscher C, Schinazi VR.

Sci Rep. 2019 Jul 1;9(1):9498. doi: 10.1038/s41598-019-45876-8.

22.

Transplanting the Untransplantable.

Holscher CM, Jackson KR, Segev DL.

Am J Kidney Dis. 2020 Jan;75(1):114-123. doi: 10.1053/j.ajkd.2019.04.025. Epub 2019 Jun 27.

PMID:
31255336
23.

Overuse of early peripheral vascular interventions for claudication.

Hicks CW, Holscher CM, Wang P, Black JH 3rd, Abularrage CJ, Makary MA.

J Vasc Surg. 2020 Jan;71(1):121-130.e1. doi: 10.1016/j.jvs.2019.05.005. Epub 2019 Jun 14.

PMID:
31208940
24.

Acute Care Surgery for Transplant Recipients: A National Survey of Surgeon Perspectives and Practices.

DiBrito SR, Bowring MG, Holscher CM, Haugen CE, Rasmussen SV, Duncan MD, Efron DT, Stevens K, Segev DL, Garonzik-Wang J, Haut ER.

J Surg Res. 2019 Nov;243:114-122. doi: 10.1016/j.jss.2019.05.008. Epub 2019 Jun 3.

PMID:
31170553
25.

Comparison of forearm versus upper arm basilic transposition arteriovenous fistulas demonstrates equivalent satisfactory patency.

Weaver ML, Holscher CM, Sorber R, Arnold MW, Lum YW, Reifsnyder T.

J Vasc Surg. 2019 Oct;70(4):1247-1252. doi: 10.1016/j.jvs.2019.01.093. Epub 2019 May 27.

PMID:
31147119
26.

The novel GLP-1/GIP dual receptor agonist DA3-CH is neuroprotective in the pilocarpine-induced epileptogenesis rat model.

Tian MJ, Wang RF, Hölscher C, Mi RL, Yuan ZY, Li DF, Xue GF.

Epilepsy Res. 2019 Aug;154:97-106. doi: 10.1016/j.eplepsyres.2019.05.008. Epub 2019 May 8.

PMID:
31121474
27.

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease.

Hölscher C.

Front Aging Neurosci. 2019 Apr 24;11:88. doi: 10.3389/fnagi.2019.00088. eCollection 2019. Review.

28.

Temporal trends and hospital costs associated with an endovascular-first approach for acute limb ischemia.

Holscher CM, Canner JK, Garonzik Wang JM, Abularrage CJ, Black JH 3rd, Hicks CW.

J Vasc Surg. 2019 Nov;70(5):1506-1513.e1. doi: 10.1016/j.jvs.2019.01.062. Epub 2019 May 5.

PMID:
31068269
29.

Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System.

Jackson KR, Zhou S, Ruck J, Massie AB, Holscher C, Kernodle A, Glorioso J, Motter J, Neu A, Desai N, Segev DL, Garonzik-Wang J.

Am J Transplant. 2019 Nov;19(11):3079-3086. doi: 10.1111/ajt.15419. Epub 2019 May 28.

PMID:
31062464
30.

Blocking IL-10 receptor signaling ameliorates Mycobacterium tuberculosis infection during influenza-induced exacerbation.

Ring S, Eggers L, Behrends J, Wutkowski A, Schwudke D, Kröger A, Hierweger AM, Hölscher C, Gabriel G, Schneider BE.

JCI Insight. 2019 Apr 18;5. pii: 126533. doi: 10.1172/jci.insight.126533.

31.

The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.

PMID:
30903733
32.

Frailty and Access to Kidney Transplantation.

Haugen CE, Chu NM, Ying H, Warsame F, Holscher CM, Desai NM, Jones MR, Norman SP, Brennan DC, Garonzik-Wang J, Walston JD, Bingaman AW, Segev DL, McAdams-DeMarco M.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):576-582. doi: 10.2215/CJN.12921118. Epub 2019 Mar 19.

PMID:
30890577
33.

Virtual navigation tested on a mobile app is predictive of real-world wayfinding navigation performance.

Coutrot A, Schmidt S, Coutrot L, Pittman J, Hong L, Wiener JM, Hölscher C, Dalton RC, Hornberger M, Spiers HJ.

PLoS One. 2019 Mar 18;14(3):e0213272. doi: 10.1371/journal.pone.0213272. eCollection 2019.

34.

Wayfinding as a Social Activity.

Dalton RC, Hölscher C, Montello DR.

Front Psychol. 2019 Feb 4;10:142. doi: 10.3389/fpsyg.2019.00142. eCollection 2019.

35.

Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

Haugen CE, Holscher CM, Luo X, Bowring MG, Orandi BJ, Thomas AG, Garonzik-Wang J, Massie AB, Philosophe B, McAdams-DeMarco M, Segev DL.

JAMA Surg. 2019 May 1;154(5):441-449. doi: 10.1001/jamasurg.2018.5568.

36.

Outcomes in Older Kidney Transplant Recipients After Prior Nonkidney Transplants.

Haugen CE, Luo X, Holscher CM, Bowring MG, DiBrito SR, Garonzik-Wang J, McAdams-DeMarco M, Segev DL.

Transplantation. 2019 Nov;103(11):2383-2387. doi: 10.1097/TP.0000000000002596.

PMID:
30747853
37.

DA-JC1 improves learning and memory by antagonizing Aβ31-35-induced circadian rhythm disorder.

Wang L, Zhang R, Hou X, Wang C, Guo S, Ning N, Sun C, Yuan Y, Li L, Hölscher C, Wang X.

Mol Brain. 2019 Feb 11;12(1):14. doi: 10.1186/s13041-019-0432-9.

38.

Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.

Zhang L, Zhang L, Li L, Hölscher C.

J Parkinsons Dis. 2019;9(1):157-171. doi: 10.3233/JPD-181503.

PMID:
30741689
39.

Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition.

Gräb J, Suárez I, van Gumpel E, Winter S, Schreiber F, Esser A, Hölscher C, Fritsch M, Herb M, Schramm M, Wachsmuth L, Pallasch C, Pasparakis M, Kashkar H, Rybniker J.

Nat Commun. 2019 Feb 8;10(1):688. doi: 10.1038/s41467-019-08405-9.

40.

Multicenter Study of Age, Frailty, and Waitlist Mortality Among Liver Transplant Candidates.

Haugen CE, McAdams-DeMarco M, Holscher CM, Ying H, Gurakar AO, Garonzik-Wang J, Cameron AM, Segev DL, Lai JC.

Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003207. [Epub ahead of print]

PMID:
30672803
41.

Offspring living kidney donors should not be ruled out.

Holscher CM, Luo X, Massie AB, Segev DL.

Am J Transplant. 2019 May;19(5):1595-1596. doi: 10.1111/ajt.15264. Epub 2019 Feb 7. No abstract available.

PMID:
30653826
42.

Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection.

Müller U, Schaub GA, Mossmann H, Köhler G, Carsetti R, Hölscher C.

Front Immunol. 2018 Dec 10;9:2794. doi: 10.3389/fimmu.2018.02794. eCollection 2018.

43.

Survival benefit of accepting livers from deceased donors over 70 years old.

Haugen CE, Bowring MG, Holscher CM, Jackson KR, Garonzik-Wang J, Cameron AM, Philosophe B, McAdams-DeMarco M, Segev DL.

Am J Transplant. 2019 Jul;19(7):2020-2028. doi: 10.1111/ajt.15250. Epub 2019 Jan 25.

PMID:
30614634
44.

Transplant waitlisting attenuates the association between hemodialysis access type and mortality.

Holscher CM, Locham SS, Haugen CE, Bae S, Segev DL, Malas MB.

J Nephrol. 2019 Jun;32(3):477-485. doi: 10.1007/s40620-018-00572-0. Epub 2019 Jan 2.

45.

Moving towards a more realistic concept of what constitutes Alzheimer's disease.

Hölscher C.

EBioMedicine. 2019 Jan;39:17-18. doi: 10.1016/j.ebiom.2018.12.030. Epub 2018 Dec 20. No abstract available.

46.

Arginase-1 Is Responsible for IL-13-Mediated Susceptibility to Trypanosoma cruzi Infection.

Abad Dar M, Hölscher C.

Front Immunol. 2018 Nov 29;9:2790. doi: 10.3389/fimmu.2018.02790. eCollection 2018.

47.

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.

Holubová M, Hrubá L, Popelová A, Bencze M, Pražienková V, Gengler S, Kratochvílová H, Haluzík M, Železná B, Kuneš J, Hölscher C, Maletínská L.

Neuropharmacology. 2019 Jan;144:377-387. doi: 10.1016/j.neuropharm.2018.11.002. Epub 2018 Nov 11.

PMID:
30428311
48.

Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD Pathology.

Nasaruddin ML, Pan X, McGuinness B, Passmore P, Kehoe PG, Hölscher C, Graham SF, Green BD.

Metabolites. 2018 Oct 26;8(4). pii: E69. doi: 10.3390/metabo8040069.

49.

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.

Jackson KR, Covarrubias K, Holscher CM, Luo X, Chen J, Massie AB, Desai N, Brennan DC, Segev DL, Garonzik-Wang J.

Am J Transplant. 2019 Apr;19(4):1129-1138. doi: 10.1111/ajt.15149. Epub 2018 Nov 26.

PMID:
30372592
50.

National Trends in Liver Transplantation in Older Adults.

Haugen CE, Holscher CM, Garonzik-Wang J, Pozo M, Warsame F, McAdams-DeMarco M, Segev DL.

J Am Geriatr Soc. 2018 Dec;66(12):2321-2326. doi: 10.1111/jgs.15583. Epub 2018 Oct 16.

Supplemental Content

Loading ...
Support Center